TCM
DMII

Tuttle Capital Management’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Tuttle Capital Management’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+10,769
New +$108K 0.07% 110

Other funds holding DMII

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $163M AUM 258.7% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Tuttle Capital Management's DMII Position: Q2 2026 in Review

Tuttle Capital Management opened a new position in Drugs Made In America Acquisition II Corp (DMII) in Q2 2026: 10,769 shares worth $108K. The stake represents 0.07% of the portfolio and ranks #110 among its holdings.

7 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Tuttle Capital Management held 10,769 shares of Drugs Made In America Acquisition II Corp worth $108K as of Q2 2026.
  • Drugs Made In America Acquisition II Corp was a new Tuttle Capital Management position in Q2 2026.
  • Drugs Made In America Acquisition II Corp made up 0.07% of Tuttle Capital Management's portfolio in Q2 2026, its #110 holding.
  • 7 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Tuttle Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.